Opthea

-$0.47 (-6.16%) Today
+$0.45 (+6.22%) As of 8:01 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Opthea and other ETFs, options, and stocks.

About OPT

Opthea Ltd. is a clinical stage biopharmaceutical company that engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It targets to treat neovascular age-related macular degeneration (wet AMD) and diabetic macular edema, which causes visual impairment among elderly and diabetic patients.

CEO
Megan Baldwin
Employees
—
Headquarters
South Yarra, Victoria (VIC)
Founded
1984

OPT Key Statistics

Market Cap
317.66M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
16.01K
High Today
$7.67
Low Today
$7.24
Open Price
$7.67
Volume
1.00K
52 Week High
$16.23
52 Week Low
$6.41

OPT Earnings

-$5.50
-$2.66
$0.17
$3.01
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 15, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure